FDA Clearance Tracker · DEN230041
Sleep Apnea Feature
Last checked: Nov 20, 2026Latest source record: Feb 6, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Feb 6, 2024
De Novo granted
Time to decision
251 days
Received May 31, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
De Novo
Direct
Device class
Class II
The decision
- FDA number
- DEN230041
- Device name
- Sleep Apnea Feature
- Applicant
- Samsung Electronics Co., Ltd.
- Applicant location
- Suwon-Si, KR
- Received
- May 31, 2023
- Decided
- Feb 6, 2024
- Decision
- De Novo granted
- Submission type
- Direct
Device type
- Device class
- Class II
- Regulation
- 21 CFR 868.2378
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- FDA granted this as a De Novo request, which means it created a new device type. There was no existing device to compare it to.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for DEN230041
- Decision summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
Other decisions for Samsung Electronics Co., Ltd.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- GC85A510(k)
K260481 · Decided Aug 27, 2026 · 195 days after receipt
Device type: System, X-Ray, Stationary (KPR) · Radiology & Imaging
- Hearing Aid Feature510(k)
K261187 · Decided Jul 31, 2026 · 112 days after receipt
Device type: Air-Conduction Hearing Aid Software (SCR) · Otolaryngology (ENT)
K261011 · Decided Jul 20, 2026 · 116 days after receipt
Device type: Over-The-Counter Device To Assess Risk Of Sleep Apnea (QZW) · Anesthesiology & Respiratory
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.